An MF provides detailed, confidential information about a product’s manufacturing, processing, packaging, and storage, including chemistry, raw materials, stability, purity, and more.
Used to support an Investigational New Drug (IND) application, Biologic License Application (BLA), New Drug Application (NDA), Abbreviated New Drug Application (ANDA), or another MF.
MFs enable manufacturers to protect intellectual property by allowing regulators at the FDA to review the contents of the MF in support of a third party’s submission.
In line with the FDA’s submission requirements, Akron submits MFs (Type II) in electronic common technical document (eCTD) format.
The FDA can cross-reference our MFs in conjunction with your IND, BLA, NDA, or ANDA. A cross-reference can be initiated via a request for a Letter of Authorization (LOA). Health Canada can also cross-reference our MF Type I filed for rHu IL-2.
The LOA is a written statement by the MF holder permitting these agencies to refer to information in the file in support of another organization’s submission.
Submit a request for an LOA by using the form to the right of this page.